Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 175 of 375 entries
View as:

Efficacy of a Couple-Focused mHealth Symptom Self-management Program

Phase: N/A Priority: Normal
NCT ID: NCT03489057 Org: User:
Start: 05/30/18 End: 07/31/22 Due: 07/31/23

Comparison of Stationary Breast Tomosynthesis and 2-D Digital Mammography in Patients With Known Breast Lesions

Phase: N/A Priority: Normal
NCT ID: NCT01773850 Org: User:
Start: 01/31/13 End: 01/31/18 Due: 01/31/19

Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00499395 Org: User:
Start: 07/31/05 End: 09/30/07 Due: 09/30/08

Study of Vorinostat With Doxil and Bortezomib for Patients With Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01492881 Org: User:
Start: 04/30/12 End: 01/31/17 Due: 01/31/18

VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06547034 Org: User:
Start: 10/16/24 End: 02/28/25 Due: 02/28/26

Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study

Phase: N/A Priority: Normal
NCT ID: NCT03846947 Org: User:
Start: 02/18/19 End: 06/21/22 Due: 06/21/23

Efalizumab in Treating Patients With Graft-Versus-Host Disease of the Skin That Did Not Respond to Previous Steroids

Phase: N/A Priority: Normal
NCT ID: NCT00489216 Org: User:
Start: 12/31/06 End: 10/31/08 Due: 10/31/09

Using PROMIS as Part of Routine Clinical Care for Racially Diverse Prostate and Bladder Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT03156244 Org: User:
Start: 05/08/17 End: 05/05/18 Due: 05/05/19

Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment

Phase: N/A Priority: Normal
NCT ID: NCT04743674 Org: User:
Start: 05/03/24 End: 01/15/27 Due: 01/15/28

Mammography Reminders for Encouraging Women to Undergo Regular Mammography Screenings for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01148875 Org: User:
Start: 09/30/04 End: 10/31/10 Due: 10/31/11

North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)

Phase: N/A Priority: Normal
NCT ID: NCT02564120 Org: User:
Start: 01/31/11 End: 12/31/18 Due: 12/31/19

Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa

Phase: N/A Priority: Normal
NCT ID: NCT05414097 Org: User:
Start: 07/16/22 End: 10/20/23 Due: 10/20/24

Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Phase: N/A Priority: Normal
NCT ID: NCT04645667 Org: User:
Start: 02/01/21 End: 10/15/23 Due: 10/15/24

PET/MRI in CNS and Extra-CNS Tumors of Patients With Neurofibromatosis-1 (NF1)

Phase: N/A Priority: Normal
NCT ID: NCT01800032 Org: User:
Start: 01/16/13 End: 12/05/19 Due: 12/05/20

High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML

Phase: N/A Priority: Normal
NCT ID: NCT02768792 Org: User:
Start: 08/22/16 End: 06/20/24 Due: 06/20/25

Study of BKM120 or BYL719 and Capecitabine in Patients With Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01300962 Org: User:
Start: 08/31/11 End: 12/31/18 Due: 12/31/19

Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT02663297 Org: User:
Start: 06/07/16 End: 01/31/37 Due: 01/31/38

Monitoring of Oral Human Papillomavirus Infection (HPV) in HPV-positive Oropharyngeal Squamous Cell Carcinoma (OPSCC)

Phase: N/A Priority: Normal
NCT ID: NCT02045186 Org: User:
Start: 12/31/13 End: 11/30/14 Due: 11/30/15

Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT01488487 Org: User:
Start: 12/31/11 End: 03/31/15 Due: 03/31/16

Engaging Clinical Champions to Improve HPV Vaccination

Phase: N/A Priority: Normal
NCT ID: NCT05736718 Org: User:
Start: 03/08/23 End: 07/01/25 Due: 07/01/26

Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)

Phase: N/A Priority: Normal
NCT ID: NCT04406714 Org: User:
Start: 07/07/20 End: 09/02/24 Due: 09/02/25

Biomarkers in Blood Samples From Older Breast Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT01138345 Org: User:
Start: 01/31/10 End: 02/28/14 Due: 02/28/15

Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT06361056 Org: User:
Start: 05/02/22 End: 01/31/26 Due: 01/31/27

ARFI, VisR and DDAI Ultrasound for Improving Discrimination of Malignant and Unresponsive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03785782 Org: User:
Start: 05/10/18 End: 07/15/21 Due: 07/15/22

High Intensity Interval Training in Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04025229 Org: User:
Start: 05/20/19 End: 09/08/25 Due: 09/08/26